{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T12:46:23Z","timestamp":1791636383015,"version":"4.3.4"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008069","name":"University of California, San Francisco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ahj.2019.10.004","type":"journal-article","created":{"date-parts":[[2019,10,20]],"date-time":"2019-10-20T17:06:58Z","timestamp":1571591218000},"page":"58-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Sex-specific cardiac phenotype and clinical outcomes in patients with hypertrophic cardiomyopathy"],"prefix":"10.1016","volume":"219","author":[{"given":"Dai-Yin","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Ventoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibani M.","family":"Kudchadkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela V.","family":"Greenland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hulya","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Effrosyni","family":"Kontari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia P.","family":"Corona-Villalobos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Styliani","family":"Vakrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan L.","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore P.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Roselle","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ahj.2019.10.004_bb0005","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jama.287.10.1308","article-title":"Hypertrophic cardiomyopathy: a systematic review","volume":"287","author":"Maron","year":"2002","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.ahj.2019.10.004_bb0010","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJM199703133361107","article-title":"The management of hypertrophic cardiomyopathy","volume":"336","author":"Spirito","year":"1997","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ahj.2019.10.004_bb0015","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jchf.2017.09.011","article-title":"Clinical spectrum and management of heart failure in hypertrophic cardiomyopathy","volume":"6","author":"Maron","year":"2018","journal-title":"JACC Heart Fail"},{"issue":"3","key":"10.1016\/j.ahj.2019.10.004_bb0020","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/CIRCULATIONAHA.105.583500","article-title":"Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy","volume":"114","author":"Harris","year":"2006","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.ahj.2019.10.004_bb0025","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1161\/CIRCULATIONAHA.106.644682","article-title":"Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction","volume":"114","author":"Maron","year":"2006","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ahj.2019.10.004_bb0030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0167-5273(00)00401-0","article-title":"Impact of gender on the left ventricular cavity size and contractility in patients with hypertrophic cardiomyopathy","volume":"77","author":"Dimitrow","year":"2001","journal-title":"Int J Cardiol"},{"issue":"7","key":"10.1016\/j.ahj.2019.10.004_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102969","article-title":"Female sex is associated with worse prognosis in patients with hypertrophic cardiomyopathy in China","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"issue":"46","key":"10.1016\/j.ahj.2019.10.004_bb0040","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1093\/eurheartj\/ehx527","article-title":"Women with hypertrophic cardiomyopathy have worse survival","volume":"38","author":"Geske","year":"2017","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.ahj.2019.10.004_bb0045","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jacc.2005.04.043","article-title":"Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy","volume":"46","author":"Olivotto","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.ahj.2019.10.004_bb0050","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ejheart.2008.06.021","article-title":"Gender-specific differences in left ventricular remodelling and fibrosis in hypertrophic cardiomyopathy: insights from cardiovascular magnetic resonance","volume":"10","author":"Schulz-Menger","year":"2008","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10.1016\/j.ahj.2019.10.004_bb0055","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ejhf.67","article-title":"Sex-specific cardiovascular structure and function in heart failure with preserved ejection fraction","volume":"16","author":"Gori","year":"2014","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/j.ahj.2019.10.004_bb0060","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/1753-6405.12753","article-title":"Age and cause-of-death contributions to area socioeconomic, sex and remoteness differences in life expectancy in New South Wales, 2010-2012","volume":"42","author":"Stephens","year":"2018","journal-title":"Aust N Z J Public Health"},{"issue":"3","key":"10.1016\/j.ahj.2019.10.004_bb0065","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/HCO.0000000000000612","article-title":"Sex differences in hypertrophic cardiomyopathy: new insights","volume":"34","author":"van Driel","year":"2019","journal-title":"Curr Opin Cardiol"},{"issue":"17","key":"10.1016\/j.ahj.2019.10.004_bb0070","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1093\/eurheartj\/ehq136","article-title":"Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy","volume":"31","author":"Melacini","year":"2010","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.ahj.2019.10.004_bb0075","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1161\/HYPERTENSIONAHA.114.03697","article-title":"Association of longitudinal changes in left ventricular structure and function with myocardial fibrosis: the Multi-Ethnic Study of Atherosclerosis study","volume":"64","author":"Ambale Venkatesh","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2019.10.004_bb0080","doi-asserted-by":"crossref","unstructured":"Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation 2011;124(24):e783\u2013831.","DOI":"10.1161\/CIR.0b013e318223e2bd"},{"issue":"8","key":"10.1016\/j.ahj.2019.10.004_bb0085","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.amjcard.2013.05.070","article-title":"Comparison of clinical presentation, left ventricular morphology, hemodynamics, and exercise tolerance in obese versus nonobese patients with hypertrophic cardiomyopathy","volume":"112","author":"Canepa","year":"2013","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.ahj.2019.10.004_bb0090","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.003116","article-title":"Predicting heart failure with preserved and reduced ejection fraction: The International Collaboration on Heart Failure Subtypes","volume":"9","author":"Ho","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"10","key":"10.1016\/j.ahj.2019.10.004_bb0095","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.amjcard.2019.02.022","article-title":"Identifying Ventricular Arrhythmias and Their Predictors by Applying Machine Learning Methods to Electronic Health Records in Patients With Hypertrophic Cardiomyopathy (HCM-VAr-Risk Model)","volume":"123","author":"Bhattacharya","year":"2019","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2019.10.004_bb0100","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/eurjhf\/hfq203","article-title":"Advantages of deformation indices over systolic velocities in assessment of longitudinal systolic function in patients with heart failure and normal ejection fraction","volume":"13","author":"Carluccio","year":"2011","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10.1016\/j.ahj.2019.10.004_bb0105","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004133","article-title":"Sex differences at the time of myectomy in hypertrophic cardiomyopathy","volume":"11","author":"Nijenkamp","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ahj.2019.10.004_bb0110","doi-asserted-by":"crossref","unstructured":"Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015;28(1):1\u201339 e14.","DOI":"10.1016\/j.echo.2014.10.003"},{"issue":"19","key":"10.1016\/j.ahj.2019.10.004_bb0115","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.jacc.2007.01.078","article-title":"Tissue Doppler imaging a new prognosticator for cardiovascular diseases","volume":"49","author":"Yu","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.ahj.2019.10.004_bb0120","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0002-9149(99)80416-0","article-title":"Provocation of latent left ventricular outflow tract gradients with amyl nitrite and exercise in hypertrophic cardiomyopathy","volume":"75","author":"Marwick","year":"1995","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.ahj.2019.10.004_bb0125","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.echo.2016.10.016","article-title":"The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography","volume":"30","author":"Lancellotti","year":"2017","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.ahj.2019.10.004_bb0130","doi-asserted-by":"crossref","unstructured":"Authors\/Task Force m, Elliott PM, Anastasakis A, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014;35(39):2733\u201379.","DOI":"10.1093\/eurheartj\/ehu284"},{"issue":"4","key":"10.1016\/j.ahj.2019.10.004_bb0135","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.amjcard.2017.05.039","article-title":"Role of global longitudinal strain in predicting outcomes in hypertrophic cardiomyopathy","volume":"120","author":"Liu","year":"2017","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.ahj.2019.10.004_bb0140","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/CIRCIMAGING.112.000110","article-title":"Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy","volume":"6","author":"Bravo","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.ahj.2019.10.004_bb0145","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/j.ejrad.2009.05.035","article-title":"Comparison of different quantification methods of late gadolinium enhancement in patients with hypertrophic cardiomyopathy","volume":"74","author":"Spiewak","year":"2010","journal-title":"Eur J Radiol"},{"issue":"4","key":"10.1016\/j.ahj.2019.10.004_bb0150","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jelectrocard.2017.02.002","article-title":"Exercise-QTc is associated with diffuse interstitial fibrosis reflected by lower approximated T1 relaxation time in hypertrophic cardiomyopathy patients","volume":"50","author":"Corona-Villalobos","year":"2017","journal-title":"J Electrocardiol"},{"issue":"12","key":"10.1016\/j.ahj.2019.10.004_bb0155","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.amjcard.2016.08.085","article-title":"Effect of diffuse subendocardial hypoperfusion on left ventricular cavity size by (13)N-ammonia perfusion PET in patients with hypertrophic cardiomyopathy","volume":"118","author":"Yalcin","year":"2016","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.ahj.2019.10.004_bb0160","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.amjcard.2012.05.038","article-title":"Comparison and effectiveness of regadenoson versus dipyridamole on stress electrocardiographic changes during positron emission tomography evaluation of patients with hypertrophic cardiomyopathy","volume":"110","author":"Bravo","year":"2012","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.ahj.2019.10.004_bb0165","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.amjcard.2018.01.022","article-title":"Stress myocardial blood flow heterogeneity is a positron emission tomography biomarker of ventricular arrhythmias in patients with hypertrophic cardiomyopathy","volume":"121","author":"Lu","year":"2018","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2019.10.004_bb0170","first-page":"488","article-title":"A simplified method for quantification of myocardial blood flow using nitrogen-13-ammonia and dynamic PET","volume":"34","author":"Choi","year":"1993","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ahj.2019.10.004_bb0175","article-title":"Higher incidence of vasodilator-induced left ventricular cavity dilation by PET when compared to treadmill exercise-ECHO in hypertrophic cardiomyopathy","author":"Lu","year":"2018","journal-title":"J Nucl Cardiol"},{"issue":"5","key":"10.1016\/j.ahj.2019.10.004_bb0180","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006657","article-title":"Clinical outcomes in patients with nonobstructive, labile and obstructive hypertrophic cardiomyopathy","volume":"7","author":"Lu","year":"2018","journal-title":"Journal of the American Heart Association"},{"issue":"2","key":"10.1016\/j.ahj.2019.10.004_bb0185","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12574-009-0030-4","article-title":"Gender differences of pulsed and tissue Doppler indexes of left ventricular diastolic function in healthy subjects","volume":"8","author":"Otsuka","year":"2010","journal-title":"J Echocardiogr"},{"issue":"1","key":"10.1016\/j.ahj.2019.10.004_bb0190","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1161\/CIRCIMAGING.108.809087","article-title":"Age- and gender-specific changes in the left ventricular relaxation: a Doppler echocardiographic study in healthy individuals","volume":"2","author":"Okura","year":"2009","journal-title":"Circ Cardiovasc Imaging"},{"issue":"23","key":"10.1016\/j.ahj.2019.10.004_bb0195","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1161\/CIRCULATIONAHA.107.698985","article-title":"Evaluation of left ventricular filling pressures by Doppler echocardiography in patients with hypertrophic cardiomyopathy: correlation with direct left atrial pressure measurement at cardiac catheterization","volume":"116","author":"Geske","year":"2007","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.ahj.2019.10.004_bb0200","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1161\/CIRCULATIONAHA.108.791681","article-title":"Determinants of left ventricular early-diastolic lengthening velocity: independent contributions from left ventricular relaxation, restoring forces","volume":"119","author":"Opdahl","year":"2009","journal-title":"and lengthening load Circulation"},{"issue":"4","key":"10.1016\/j.ahj.2019.10.004_bb0205","first-page":"438","article-title":"Mitral E wave propagation as an index of left ventricular diastolic function. I: Its hydrodynamic basis","volume":"7","author":"Pai","year":"1998","journal-title":"J Heart Valve Dis"},{"issue":"4","key":"10.1016\/j.ahj.2019.10.004_bb0210","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4250\/jcu.2011.19.4.169","article-title":"Limitations of E\/e' to Assess Left Ventricular Filling Pressure by Echocardiography","volume":"19","author":"Park","year":"2011","journal-title":"J Cardiovasc Ultrasound"},{"issue":"9","key":"10.1016\/j.ahj.2019.10.004_bb0215","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/ejhf.1250","article-title":"The strengths and limitations of E\/e' in heart failure with preserved ejection fraction","volume":"20","author":"Obokata","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10.1016\/j.ahj.2019.10.004_bb0220","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.jacc.2016.12.037","article-title":"Test in Context: E\/A and E\/e' to Assess Diastolic Dysfunction and LV Filling Pressure","volume":"69","author":"Mitter","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ahj.2019.10.004_bb0225","first-page":"75","article-title":"Myocardial blood flow measurement by PET: technical aspects and clinical applications","volume":"46","author":"Kaufmann","year":"2005","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.ahj.2019.10.004_bb0230","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/01.CIR.92.1.24","article-title":"17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease","volume":"92","author":"Collins","year":"1995","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ahj.2019.10.004_bb0235","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jjcc.2010.07.004","article-title":"Gender-specific differences in the clinical features of hypertrophic cardiomyopathy in a community-based Japanese population: results from Kochi RYOMA study","volume":"56","author":"Kubo","year":"2010","journal-title":"J Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2019.10.004_bb0240","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.cardiores.2004.03.027","article-title":"Gender modulates cardiac phenotype development in genetically modified mice","volume":"63","author":"Du","year":"2004","journal-title":"Cardiovasc Res"},{"issue":"15","key":"10.1016\/j.ahj.2019.10.004_bb0245","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1161\/01.CIR.100.15.1639","article-title":"Estrogen inhibits vascular smooth muscle cell-dependent adventitial fibroblast migration in vitro","volume":"100","author":"Li","year":"1999","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ahj.2019.10.004_bb0250","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0008-6363(03)00496-6","article-title":"Estrogen receptor beta mediates the inhibitory effect of estradiol on vascular smooth muscle cell proliferation","volume":"59","author":"Watanabe","year":"2003","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.ahj.2019.10.004_bb0255","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-5793(97)01179-4","article-title":"Cardiac myocytes and fibroblasts contain functional estrogen receptors","volume":"416","author":"Grohe","year":"1997","journal-title":"FEBS Lett"},{"issue":"11","key":"10.1016\/j.ahj.2019.10.004_bb0260","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1210\/me.2010-0154","article-title":"Estrogen receptor-beta prevents cardiac fibrosis","volume":"24","author":"Pedram","year":"2010","journal-title":"Mol Endocrinol"},{"issue":"3","key":"10.1016\/j.ahj.2019.10.004_bb0265","doi-asserted-by":"crossref","first-page":"C310","DOI":"10.1152\/ajpcell.00060.2017","article-title":"Neonatal cardiomyocyte hypertrophy induced by endothelin-1 is blocked by estradiol acting on GPER","volume":"314","author":"Goncalves","year":"2018","journal-title":"Am J Physiol Cell Physiol"},{"issue":"8","key":"10.1016\/j.ahj.2019.10.004_bb0270","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/ATVBAHA.109.191221","article-title":"Estrogen receptors and endothelium","volume":"30","author":"Arnal","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.ahj.2019.10.004_bb0275","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/01.CIR.0000105682.85732.BD","article-title":"17beta-estradiol antagonizes cardiomyocyte hypertrophy by autocrine\/paracrine stimulation of a guanylyl cyclase A receptor-cyclic guanosine monophosphate-dependent protein kinase pathway","volume":"109","author":"Babiker","year":"2004","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ahj.2019.10.004_bb0280","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1161\/hh1001.090858","article-title":"Myocardial Akt activation and gender: increased nuclear activity in females versus males","volume":"88","author":"Camper-Kirby","year":"2001","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.ahj.2019.10.004_bb0285","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0002-8703(96)90357-9","article-title":"New insights into the reduction of mitral valve systolic anterior motion after ventricular septal myectomy in hypertrophic obstructive cardiomyopathy","volume":"131","author":"Nakatani","year":"1996","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.ahj.2019.10.004_bb0290","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1161\/01.CIR.97.1.41","article-title":"Mechanism of benefit of negative inotropes in obstructive hypertrophic cardiomyopathy","volume":"97","author":"Sherrid","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2019.10.004_bb0295","unstructured":"Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy. In."},{"issue":"Suppl 1","key":"10.1016\/j.ahj.2019.10.004_bb0300","first-page":"A20593","article-title":"Abstract 20593: <em>In vivo<\/em> Cardiac Effects of Mavacamten (MYK-461): Evidence for Negative Inotropy and Improved Compliance","volume":"136","author":"del Rio","year":"2017","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ahj.2019.10.004_bb0305","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0002-9440(10)63694-2","article-title":"Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy","volume":"163","author":"Ponten","year":"2003","journal-title":"and dilated cardiomyopathy Am J Pathol"},{"issue":"3","key":"10.1016\/j.ahj.2019.10.004_bb0310","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1095-6433(02)00347-1","article-title":"Influence of gender on ethanol-induced ventricular myocyte contractile depression in transgenic mice with cardiac overexpression of alcohol dehydrogenase","volume":"134","author":"Duan","year":"2003","journal-title":"Comp Biochem Physiol A Mol Integr Physiol"},{"issue":"10 Supplement","key":"10.1016\/j.ahj.2019.10.004_bb0315","doi-asserted-by":"crossref","first-page":"A788","DOI":"10.1016\/S0735-1097(15)60788-4","article-title":"Patients with genotype-positive hypertrophic cardiomyopathy are at increased risk of heart failure related death","volume":"65","author":"van Velzen","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.ahj.2019.10.004_bb0320","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","article-title":"Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe)","volume":"138","author":"Ho","year":"2018","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ahj.2019.10.004_bb0325","first-page":"146","article-title":"Factors influencing the phenotypic expression of hypertrophic cardiomyopathy in genetic carriers","volume":"71","author":"Perez-Sanchez","year":"2018","journal-title":"Rev Esp Cardiol (Engl Ed)"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870319302790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870319302790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:03:20Z","timestamp":1757570600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870319302790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":65,"alternative-id":["S0002870319302790"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2019.10.004","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex-specific cardiac phenotype and clinical outcomes in patients with hypertrophic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2019.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}